Going ahead, the brokerage sees limited short-term upside for the Nifty due to high valuations and a lack of positive catalysts. Despite this, the pause is viewed as a temporary phase in a long-term bull market, with a low likelihood of a significant correction. SAMCO maintains a positive outlook on […]
Metropolis Healthcare
Additionally, HDFC Securities has assigned an ‘add’ rating to Max Healthcare Institute, Dr. Lal PathLabs, and Metropolis Healthcare, with price targets of ₹900, ₹2,700, and ₹2,010, respectively. The brokerage anticipates that India’s healthcare sector is on track for continuous expansion, driven by factors such as an aging population, a rise […]
The brokerage emphasised that the Indian healthcare landscape post pandemic is poised to capitalise on structural tailwinds such as heightened consumer awareness, favorable demographics, rise in lifestyle related diseases, and substantial public sector investments in infrastructure. Also Read: Market Meltdown: Indian stocks lag behind global peers in May – key […]